Progyny, Inc. (PGNY): who owns it and who trades it
As of Nov 16, 2026, PGNY insiders reported 38 open-market sales worth $24.5M and no purchases in the last 12 months, with 96% of the sale value made under pre-set 10b5-1 plans. The largest seller was Peter Anevski (CEO), with $14.7M. 4 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Progyny
From the latest filingsOverall: more selling than buying. Insiders and famous investors mostly sold. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns PGNY
311 funds and institutions reported PGNY shares worth $2.4B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 14.8%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 11.60M | 14.81% | $334M | -3% |
| FMR LLC (Fidelity) | 7.00M | 8.94% | $202M | +8% |
| Vanguard Portfolio Management LLC | 5.02M | 6.41% | $145M | -5% |
| Vanguard Capital Management LLC | 3.21M | 4.10% | $92.6M | -8% |
| State Street Corp | 3.02M | 3.86% | $87.1M | -2% |
| Ameriprise Financial Inc | 2.76M | 3.53% | $79.7M | -2% |
| Fort Washington Investment Advisors Inc | 2.55M | 3.25% | $73.5M | -5% |
| California State Teachers Retirement System | 2.39M | 3.06% | $83M | +2299% |
| Geode Capital Management, LLC | 1.97M | 2.51% | $56.8M | -4% |
| Citadel Advisors LLC | 1.79M | 2.28% | $51.5M | – |
| Dimensional Fund Advisors LP | 1.69M | 2.16% | $48.7M | +7% |
| Soleus Capital Management, L.P. | 1.60M | 2.05% | $46.2M | -22% |
| Morgan Stanley | 1.54M | 1.96% | $44.3M | -33% |
| Wellington Management Group LLP | 1.50M | 1.91% | $43.1M | -35% |
| Disciplined Growth Investors Inc | 1.18M | 1.51% | $34.1M | +106% |
| Loomis Sayles & Co L P | 1.08M | 1.38% | $31.2M | +9% |
| Baillie Gifford & Co | 1.08M | 1.38% | $31.1M | -12% |
| Jane Street Group, LLC | 1.06M | 1.36% | $30.7M | +614% |
| Easterly Investment Partners LLC | 958,117 | 1.22% | $27.6M | +15% |
| Charles Schwab Investment Management Inc | 954,065 | 1.22% | $27.5M | +19% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, PGNY insiders reported $0 of open-market purchases and $24.5M of sales. 96% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Geoffrey Clapp | Chief Product Officer | Sale plan | 774 | $36.41 | $28.2K | Form 4 |
| Nov 10, 2026 | Peter Anevski | CEO | Sale plan | 120,213 | $35.61 | $4.3M | Form 4 |
| Nov 10, 2026 | Peter Anevski | CEO | Sale plan | 64,921 | $36.29 | $2.4M | Form 4 |
| Nov 10, 2026 | Peter Anevski | CEO | Sale plan | 33,437 | $35.61 | $1.2M | Form 4 |
| Nov 10, 2026 | Peter Anevski | CEO | Sale plan | 18,059 | $36.29 | $655K | Form 4 |
| Nov 10, 2026 | David J Schlanger | Chair | Sale plan | 35,392 | $35.36 | $1.3M | Form 4 |
| Nov 9, 2026 | Peter Anevski | CEO | Sale plan | 126,204 | $35.73 | $4.5M | Form 4 |
| Nov 9, 2026 | Peter Anevski | CEO | Sale plan | 35,104 | $35.73 | $1.3M | Form 4 |
| Nov 9, 2026 | David J Schlanger | Chair | Sale plan | 161,208 | $35.73 | $5.8M | Form 4 |
| Nov 5, 2026 | Peter Anevski | CEO | Sale plan | 3,400 | $35.23 | $120K | Form 4 |
| Nov 5, 2026 | Peter Anevski | CEO | Sale plan | 8,539 | $35.09 | $300K | Form 4 |
| Nov 5, 2026 | David J Schlanger | Chair | Sale plan | 3,400 | $35.22 | $120K | Form 4 |
| Nov 4, 2026 | Mark S. Livingston | CFO | Sale plan | 2,139 | $30.00 | $64.2K | Form 4 |
| Oct 14, 2026 | Melissa B Cummings | Chief Operating Officer | Sale plan | 1,879 | $28.00 | $52.6K | Form 4 |
| Sep 23, 2026 | Allison Swartz | Vice president | Sale plan | 3,903 | $26.10 | $102K | Form 4 |
| Sep 10, 2026 | Kevin K Gordon | Director | Sale | 11,500 | $27.12 | $312K | Form 4 |
| Sep 10, 2026 | Kevin K Gordon | Director | Sale | 11,500 | $27.94 | $321K | Form 4 |
| Jul 14, 2026 | Melissa B Cummings | Chief Operating Officer | Sale plan | 2,244 | $31.60 | $70.9K | Form 4 |
| Jun 4, 2026 | Mark S. Livingston | CFO | Sale plan | 599 | $25.50 | $15.3K | Form 4 |
| Jun 4, 2026 | Mark S. Livingston | CFO | Sale plan | 1,918 | $25.50 | $48.9K | Form 4 |
| Jun 4, 2026 | Allison Swartz | Vice president | Sale plan | 599 | $25.08 | $15K | Form 4 |
| Jun 3, 2026 | Allison Swartz | Vice president | Sale plan | 1,199 | $25.02 | $30K | Form 4 |
| Jun 2, 2026 | Mark S. Livingston | CFO | Sale plan | 279 | $26.20 | $7.3K | Form 4 |
| Jun 2, 2026 | Geoffrey Clapp | Chief Product Officer | Sale | 1,530 | $25.58 | $39.1K | Form 4 |
| Jun 1, 2026 | Cheryl Scott | Director | Sale | 7,439 | $26.39 | $196K | Form 4 |
| May 28, 2026 | Allison Swartz | Vice president | Sale plan | 2,398 | $25.46 | $61.1K | Form 4 |
| May 27, 2026 | Kevin K Gordon | Director | Sale | 5,500 | $24.99 | $137K | Form 4 |
| May 20, 2026 | Mark S. Livingston | CFO | Sale plan | 8,275 | $25.50 | $211K | Form 4 |
| May 19, 2026 | Melissa B Cummings | Chief Operating Officer | Sale plan | 9,578 | $25.00 | $239K | Form 4 |
| Mar 4, 2026 | Allison Swartz | Vice president | Sale plan | 599 | $17.54 | $10.5K | Form 4 |
| Mar 3, 2026 | Allison Swartz | Vice president | Sale plan | 4,157 | $17.40 | $72.3K | Form 4 |
| Mar 3, 2026 | Allison Swartz | Vice president | Sale plan | 500 | $17.40 | $8.7K | Form 4 |
| Mar 2, 2026 | Allison Swartz | Vice president | Sale plan | 2,199 | $17.27 | $38K | Form 4 |
| Dec 11, 2025 | Mark S. Livingston | CFO | Sale plan | 459 | $25.50 | $11.7K | Form 4 |
| Dec 4, 2025 | Allison Swartz | Vice president | Sale plan | 530 | $24.59 | $13K | Form 4 |
| Dec 2, 2025 | Mark S. Livingston | CFO | Sale plan | 213 | $25.50 | $5.4K | Form 4 |
| Nov 28, 2025 | Allison Swartz | Vice president | Sale plan | 2,398 | $26.87 | $64.4K | Form 4 |
| Nov 17, 2025 | Mark S. Livingston | CFO | Sale plan | 21,303 | $25.50 | $543K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Peter Anevski | CHIEF EXECUTIVE OFFICER, Director | – | $14.7M | Nov 10, 2026 |
| David J Schlanger | Executive Chairman, Director | – | $7.1M | Nov 10, 2026 |
| Mark S. Livingston | CHIEF FINANCIAL OFFICER | – | $907K | Nov 4, 2026 |
| Kevin K Gordon | Director | – | $771K | Sep 10, 2026 |
| Allison Swartz | EVP, GC | – | $415K | Sep 23, 2026 |
| Melissa B Cummings | Chief Operating Officer | – | $363K | Oct 14, 2026 |
| Cheryl Scott | Director | – | $196K | Jun 1, 2026 |
| Geoffrey Clapp | Chief Product Officer | – | $67.3K | Nov 11, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
PGNY short interest
Moderate short interest. 6.2% of PGNY shares are sold short: about 1 share in 16. Over the last 12 reports the number of shares short went down 12%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 4.76M PGNY shares were sold short, 6.2% of the shares outstanding, down 1.9% from the report before. At the average daily volume of 760,534 shares, buying them all back would take about 6.3 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 4.76M | 6.20% | -2% | 760,534 | 6.3 |
| Oct 15, 2026 | 4.85M | 6.32% | -5% | 1.14M | 4.2 |
| Sep 30, 2026 | 5.09M | 6.64% | +8% | 1.25M | 4.1 |
| Sep 15, 2026 | 4.71M | 6.14% | +6% | 1.02M | 4.6 |
| Aug 31, 2026 | 4.45M | 5.80% | -3% | 983,121 | 4.5 |
| Aug 14, 2026 | 4.57M | 5.96% | +2% | 1.32M | 3.5 |
| Jul 31, 2026 | 4.49M | 5.85% | -3% | 972,110 | 4.6 |
| Jul 15, 2026 | 4.63M | 5.91% | +3% | 1.26M | 3.7 |
| Jun 30, 2026 | 4.49M | 5.74% | -6% | 1.48M | 3.0 |
| Jun 15, 2026 | 4.81M | 6.13% | -5% | 1.40M | 3.4 |
| May 29, 2026 | 5.08M | 6.49% | -6% | 1.61M | 3.1 |
| May 15, 2026 | 5.42M | 6.92% | -14% | 1.92M | 2.8 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded PGNY
Since Nov 17, 2024, 1 member of Congress reported 0 purchases and 1 sale of PGNY. The latest was a sale by Josh Gottheimer on Dec 6, 2024, reported Jan 14, 2025.
Purchases 0Sales 1
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| Dec 6, 2024 | Josh Gottheimer (D-NJ) | Sale | $1K–$15K | Joint | Jan 14, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Progyny company events
Progyny filed 9 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Nov 4, 2026.
- Nov 4, 2026ResultsReleased financial results. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- May 27, 2026VoteReported shareholder vote results. Filing
- May 26, 2026AnnouncementProgyny, Inc. announced today that its Board of Directors has approved a share repurchase program to repurchase up to $200 million of its common stock. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Mar 13, 2026AnnouncementProgyny, Inc. issued a Notice of Pendency of Settlement of Derivative Action, which is attached hereto as Exhibit 99.1, in accordance with the terms of a settlement agreement the Company entered into with a stockholder of the Company to resolve an action brought derivatively on behalf of the… Filing
- Feb 26, 2026ResultsReleased financial results. Filing
- Jan 12, 2026ResultsReleased financial results. Filing
- Dec 17, 2025LeadershipProgyny, Inc. announced that the employment of Michael Sturmer, the Company’s President, will cease, effective as of December 31, 2025. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Progyny financials
Famous investors that hold PGNY
4 of the 50 well-known investors we track reported holding PGNY in their latest 13F filing. The largest position is Ken Griffin's, worth $19.8M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 786,441 | $19.8M | 0.0% | -56% |
| Israel Englander · Millennium Management | Q3 2026 | 392,292 | $9.9M | 0.0% | -11% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 290,467 | $7.3M | 0.0% | -32% |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 199,886 | $5M | 0.0% | +286% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named PGNY in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Oct 27, 2026 | BlackRock, Inc. | 13G/A | 14.7% |
| Oct 27, 2026 | BlackRock, Inc. | 13G/A | 14.7% |
Questions about Progyny, Inc. (PGNY) stock
Who owns the most PGNY stock?
The largest reported owner of Progyny, Inc. (PGNY) is BlackRock, Inc., with 14.8% of the company. In total, 311 funds and institutions reported holding PGNY at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are PGNY insiders buying or selling?
In the last 12 months, PGNY insiders reported no open-market purchases and 38 sales worth $24.5M. The latest trade was on Nov 11, 2026. See every trade.
What is the short interest in PGNY?
As of Oct 30, 2026, 4.76M PGNY shares were sold short, 6.2% of the shares outstanding, down 1.9% from the report before. At the average daily volume of 760,534 shares, buying them all back would take about 6.3 trading days (days to cover). See the history.
Have members of Congress traded PGNY?
Yes. 1 member of Congress reported 0 purchases and 1 sale of PGNY since Nov 17, 2024. The latest was reported on Jan 14, 2025. See the trades.
Which famous investors hold PGNY?
4 of the 50 well-known investors we track reported PGNY in their latest 13F filing, including Ken Griffin, Israel Englander, Jim Simons. The largest position is worth $19.8M. See all holders.
Executive pay
Progyny's chief executive was paid a total of $7.2M for the year ended Dec 31, 2025, up 430% from $1.4M the year before. In the last 12 months, Progyny's executives and directors bought $1.9M of stock on the open market and sold $24.5M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.